The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology

[1]  G. Barkan.  Enough is enough: Adequacy of voided urine cytology , 2016, Cancer cytopathology.

[2]  C. VandenBussche,et al.  Adequacy in voided urine cytology specimens: The role of volume and a repeat void upon predictive values for high‐grade urothelial carcinoma , 2016, Cancer cytopathology.

[3]  S. Pambuccian,et al.  Accuracy and interobserver variability of the cytologic diagnosis of low-grade urothelial carcinoma in instrumented urinary tract cytology specimens. , 2015, American journal of clinical pathology.

[4]  S. Pambuccian,et al.  What Is the Negative Predictive Value of Urinary Tract Cytology , 2015 .

[5]  G. Barkan,et al.  Subclassifying atypia in urine cytology: what are the helpful features? , 2015, Journal of the American Society of Cytopathology.

[6]  S. Pambuccian,et al.  Evidence-based adequacy criteria for urinary bladder barbotage cytology. , 2015, Journal of the American Society of Cytopathology.

[7]  M. Mino‐Kenudson,et al.  Standardized terminology and nomenclature for pancreatobiliary cytology: The Papanicolaou Society of Cytopathology Guidelines , 2014, CytoJournal.

[8]  G. Netto.  Molecular genetics and genomics progress in urothelial bladder cancer. , 2013, Seminars in diagnostic pathology.

[9]  Robert P Berkowitz,et al.  2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. , 2013, Obstetrics and gynecology.

[10]  J. Srigley,et al.  Standardized synoptic cancer pathology reports - so what and who cares? A population-based satisfaction survey of 970 pathologists, surgeons, and oncologists. , 2013, Archives of pathology & laboratory medicine.

[11]  C. VandenBussche,et al.  The Johns Hopkins Hospital template for urologic cytology samples , 2013, Cancer cytopathology.

[12]  E. Leteurtre,et al.  The official nomenclature and terminologies in diagnostic cytopathology: history, evolution, applicability and future. , 2012, Annales de pathologie.

[13]  S. Nazir,et al.  Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic , 2012, BJU international.

[14]  David C Wilbur,et al.  The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. , 2012, Journal of lower genital tract disease.

[15]  S. Koenig,et al.  Endobronchial ultrasound‐guided transbronchial needle aspirate (EBUS‐TBNA):A proposal for on‐site adequacy criteria , 2012, Diagnostic cytopathology.

[16]  L. Bubendorf,et al.  Evaluation of chromosomal aberrations in patients with benign conditions and reactive changes in urinary cytology , 2011, Cancer cytopathology.

[17]  O. Yossepowitch,et al.  Clinically unconfirmed positive urinary cytology: diagnostic implications and oncological outcomes , 2011, BJU international.

[18]  Liang Cheng,et al.  Bladder cancer: translating molecular genetic insights into clinical practice. , 2011, Human pathology.

[19]  L. Mazzucchelli,et al.  The Bethesda System for reporting thyroid fine-needle aspiration specimens. , 2010, American journal of clinical pathology.

[20]  A. Clayton,et al.  Guidelines for the reporting of nongynecologic cytopathology specimens. , 2009, Archives of pathology & laboratory medicine.

[21]  F. Brimo,et al.  Accuracy of urine cytology and the significance of an atypical category. , 2009, American journal of clinical pathology.

[22]  E. Cibas,et al.  The Bethesda System for Reporting Thyroid Cytopathology , 2009, Springer International Publishing.

[23]  Ewout W Steyerberg,et al.  Cystoscopy revisited as the gold standard for detecting bladder cancer recurrence: diagnostic review bias in the randomized, prospective CEFUB trial. , 2009, The Journal of urology.

[24]  S. Pambuccian,et al.  Endobronchial ultrasound-guided transbronchial fine-needle aspiration: the University of Minnesota experience, with emphasis on usefulness, adequacy assessment, and diagnostic difficulties. , 2008, American journal of clinical pathology.

[25]  M. Knowles,et al.  Molecular pathogenesis of bladder cancer , 2008, International Journal of Clinical Oncology.

[26]  P. Schellhammer,et al.  Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. , 2007, The Journal of urology.

[27]  M. Schiffman,et al.  The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays. , 2007, American journal of clinical pathology.

[28]  B. Yoder,et al.  Perceptions of diagnostic terminology and cytopathologic reporting of fine-needle aspiration biopsies of thyroid nodules: a survey of clinicians and pathologists. , 2006, Thyroid : official journal of the American Thyroid Association.

[29]  L. Bubendorf,et al.  An international telecytologic quiz on urinary cytology reveals educational deficits and absence of a commonly used classification system. , 2006, American journal of clinical pathology.

[30]  R. Nayar,et al.  Review of the state of the art and recommendations of the Papanicolaou Society of Cytopathology for urinary cytology procedures and reporting : The Papanicolaou Society of Cytopathology Practice Guidelines Task Force , 2004, Diagnostic cytopathology.

[31]  S. Raab,et al.  Low‐grade urothelial carcinoma: Reappraisal of the cytologic criteria on ThinPrep® , 2003, Diagnostic cytopathology.

[32]  M. Schiffman,et al.  Findings to date from the ASCUS-LSIL Triage Study (ALTS). , 2003, Archives of pathology & laboratory medicine.

[33]  M. Henry,et al.  Effect of Cellularity on the Sensitivity of Detecting Squamous Lesions in Liquid-Based Cervical Cytology , 2003, Acta Cytologica.

[34]  P. Kimmel,et al.  Hematuria: an algorithmic approach to finding the cause. , 2002, Cleveland Clinic journal of medicine.

[35]  J. T. Cox,et al.  ASCCP Patient Management Guidelines: Pap Test Specimen Adequacy and Quality Indicators , 2002, Journal of lower genital tract disease.

[36]  A. Renshaw.  Subclassifying atypical urinary cytology specimens , 2000, Cancer.

[37]  R. Jenkins,et al.  The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. , 2000, The Journal of molecular diagnostics : JMD.

[38]  S M Powsner,et al.  Clinicians are from Mars and pathologists are from Venus. , 2000, Archives of pathology & laboratory medicine.

[39]  M. Cohen,et al.  Low-grade transitional cell carcinoma of the urinary bladder: application of select cytologic criteria to improve diagnostic accuracy [corrected]. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[40]  S. Raab,et al.  Low grade transitional cell carcinoma of the bladder. Cytologic Diagnosis by Key Features as Identified by Logistic Regression Analysis , 1994, Cancer.

[41]  P. McCarthy,et al.  Long-term follow-up of patients with benign thyroid fine-needle aspiration cytologic diagnoses. , 1989, Surgery.

[42]  H. Gharib,et al.  Fine needle aspiration cytology of the thyroid, 1980 to 1986. , 1987, Acta cytologica.

[43]  W M Murphy,et al.  Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms , 1984, Cancer.

[44]  G. Papanicolaou,et al.  URINE SEDIMENT SMEARS AS A DIAGNOSTIC PROCEDURE IN CANCERS OF THE URINARY TRACT. , 1945, Science.

[45]  Eva M. Wojcik.  What should not be reported as atypia in urine cytology. , 2015, Journal of the American Society of Cytopathology.

[46]  A. Osunkoya,et al.  Accuracy of grading of urothelial carcinoma on urine cytology: an analysis of interobserver and intraobserver agreement. , 2012, International journal of clinical and experimental pathology.

[47]  B. V. van Rhijn.  Combining molecular and pathologic data to prognosticate non-muscle-invasive bladder cancer. , 2012, Urologic oncology.

[48]  A. Ruffion,et al.  [Atypical urothelial cells (AUC): A Bethesda-derived wording applicable to urinary cytopathology]. , 2011, Annales de pathologie.

[49]  D. Solomon,et al.  The Bethesda system for reporting cervical cytology : definitions, criteria, and explanatory notes , 2004 .

[50]  H. Ozen.  Bladder cancer. , 1998, Current opinion in oncology.

[51]  The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. National Cancer Institute Workshop. , 1989, JAMA.